Mahmoud AAF and Woodruff AW. Mechanisms involved in the anemia of schistosomiasis. Trans R Soc Trop Med Hyg 66:75‑84, 1972.
Mahmoud AAF and Woodruff AW. The contribution of adult worms to the development of anemia in schistosomiasis. Trans R Soc Trop Med Hyg 67:171‑173, 1973.
Woodruff AW, Monath TP, Mahmoud AAF, Pain AK and Morris CA. Lassa fever in Britain . Br Med J 3:616‑617, 1973.
Mahmoud AAF, Warren KS and Boros DL. Production of a rabbit antimouse eosinophil serum with no cross‑reactivity to neutrophils. J Exp Med 137: 1526‑1531, 1973.
Mahmoud AAF and Warren KS nti‑inflammatory effects of tartar emetic and niridazole: Suppression of schistosome egg granuloma. J Immunol 112: 222‑228, 1974.
Mahmoud AAF, Kellermeyer RW and Warren KS. Production of a monospecific rabbit antihuman eosinophil serum with demonstration of a blocking phenomenon. N Engl J Med 290: 417‑420, 1974.
Warren KS, Mahmoud AAF, Boros DL, Rall TW, Mandel MA and Carpenter CCJ, Jr. In vivo suppression by cholera toxin of cell‑mediated and foreign body inflammatory responses. J Immunol 112: 996‑1007, 1974.
Warren KS, Mahmoud AAF, Cummings P, Murphy DJ and Houser HB. Schistosomiasis mansoni in Yemeni in California : Duration of infection, presence of disease, therapeutic management. Am J Trop Med Hyg 23: 902‑909, 1974.
Davis BH, Mahmoud AAF and Warren KS. Granulomatous hypersensitivity in thymectomized and bursectomized chickens. J Immunol 113: 1064‑1067, 1974.
Mahmoud AAF, Kellermeyer RW and Warren KS. Monospecific anti‑granulocyte sera against human neutrophils, eosinophils, basophils and myeloblasts. Lancet 2:1163‑1166, 1974.
Mahmoud AAF et al. Immunology of schistosomiasis. Bull WHO 51: 553‑595, 1974.
Mahmoud AAF, Mandel MA, Warren KS and Webster LT Jr. Niridazole II: A potent long‑acting suppressant of cellular hypersensitivity. J Immunol 114: 279‑283, 1975.
Mahmoud AAF and Woodruff AW. Renal lesions caused by immune complex deposition in schistosomiasis. Trans R Soc Trop Med Hyg. 69: 187‑188, 1975.
Mahmoud AA., Cheever AW and Warren KS. Streptozotocin‑induced diabetes mellitus and the host‑parasite relation in murine schistosomiasis mansoni. J Infect Dis 131: 634‑642, 1975.
Warren KS, Boros DL, Hang LM and Mahmoud AAF. The Schistosoma japonicum egg granuloma. Am J Pathol 80: 279‑294, 1975.
Webster LT Jr, Butterworth AE, Mahmoud AAF, Mngola EN and Warren KS. Suppression of delayed hypersensitivity in schistosome‑infected humans by niridazole. N Engl J Med 292: 1144‑1147, 1975.
Mahmoud AAF, Warren KS and Graham RC Jr. Antieosinophil serum and the kinetics of eosinophilia in schistosomiasis mansoni. J Exp Med 142: 560‑574, 1975.
Butterworth AE, Sturrock RF, Houba V, Mahmoud AAF, Sher A and Rees PH. Eosinophils as mediators of antibody dependent damage to schistosomula. Nature 256: 727‑729, 1975.
Mahmoud AAF, Warren KS and Peters PA. A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum. J Exp Med 142: 805‑813, 1975.
Kazura JW, Mahmoud AAF, Karb KS and Warren KS. The lymphokine "Eosinophil Stimulation Promoter" and human schistosomiasis mansoni. J Infec. Dis 132: 702‑706, 1975.
Pelley RP, Pelley RJ, Stavitsky AB , Mahmoud AAF and Warren KS. Niridazole, a potent long‑acting suppressant of cellular hypersensitivity. III: Minimal suppression of antibody responses. J Immunol 115: 1477‑1482, 1975.
Peters PA, Warren KS and Mahmoud AAF. Rapid, accurate quantification of schistosome eggs via Nucleopore filters. J Parasitol 62: 154, 1976.
Siongok TKA, Mahmoud AAF, Ouma JH, Warren KS, Muller AS, Handa AK and Houser HB. Morbidity in schistosomiasis mansoni in relation to intensity of infection: Study of a community in Machakos , Kenya . Am J Trop Med Hyg 25: 273‑283, 1976.
Mahmoud AAF, Rodman HM, Mandel MA and Warren KS. Induced and spontaneous diabetes mellitus and suppression of cell‑mediated immunologic responses: Granuloma formation delayed dermal reactivity, allograft rejection. J Clin Invest 57: 362‑367, 1976.
Roberts‑Thomson IC, Stevens DP, Mahmoud AAF and Warren KS. Giardiasis in the mouse: an animal model. Gastroenterology 71: 57‑61, 1976.
Mahmoud AAF, Warren KS and Strickland GT. Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasmosis gondii. Nature 263: 56‑57, 1976.
Houba V, Koech DK, Sturrock RF, Butterworth AE, Kusel JR and Mahmoud AAF. Soluble antigens and antibodies in sera from baboons infected with Schistosoma mansoni. J Immunol 117: 705‑707, 1976.
Deodhar SD , Lee V, Chiang T, Mahmoud AAF and Warren KS. Effects of the immunosuppressive drug niridazole in isogeneic and allogeneic mouse tumor systems in vivo: Enhancement of metastases with suppression of tumor growth. Cancer Res 36: 3147‑3150, 1976.
Pelley RP, Karp R, Mahmoud AAF and Warren KS. Antigen dose response and specificity of production of the lymphokine, eosinophil stimulation promoter. J Infect Dis 134: 230‑237, 1976.
Warren K., Karp R, Pelley R. and Mahmoud AAF. The Eosinophil Stimulation Promoter test in murine and human Trichinella spiralis infection. J Infect Dis 134: 277‑280, 1976.
Peters PA, Mahmoud AAF, Warren KS, Ouma JH and Siongok TK Arap. Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bull WHO 54: 159‑162, 1976.
Roberts‑Thomson IC, Stevens DP, Mahmoud AA. and Warren KS. Acquired resistance to infection in an animal model of giardiasis. J Immunol 117: 2036‑2037, 1976.
Warren KS and Mahmoud AAF. Targeted mass treatment: a new approach to the control of schistosomiasis. Trans Assoc Am Physicians 89: 195‑204, 1976.
Butterworth AE, David JR, Franks D, Mahmoud AAF, David PH, Sturrock RF and Houba V. Antibody‑dependent eosinophil‑mediated damage to 51Cr‑labeled schistosomula by Schistosoma mansoni: Damage by purified eosinophils. J Exp Med 145: 136‑150, 1977.
Mahmoud AAF, Strickland GT and Warren KS. Toxoplasmosis and the host‑parasite relationship in murine schistosomiasis mansoni. J Infect Dis 135:408‑413, 1977.
Grove DI, Mahmoud AA. and Warren KS. Eosinophils and resistance to Trichinella spiralis. J Exp Med 145:755‑759, 1977.
Grove DI, Mahmoud AAF and Warren KS. Suppression of cell‑mediated immunity by metronidazole. Int Arch Allergy Appl Immunol 54:422‑427, 1977.
Mahmoud AAF, Stone MK and Kellermeyer RW. Eosinophilopoietin: a circulating low‑molecular weight peptide‑like substance that stimulates the production of eosinophils in mice. J Clin Invest 60:675‑682, 1977.
Mahmoud AAF. Antieosinophil serum. Proceedings, Immunology of Parasitic Infections, Bethesda , Maryland , June 1977. Am J Trop Med Hyg 26(Suppl.): 51‑158, 1977.
Warren KS, Pelley RP and Mahmoud AAF. Immunity and immunopathology following reinfection of mice cured of chronic schistosomiasis mansoni. Am J Trop Med Hyg 26:957‑962, 1977.
Mahmoud AAF. Current concepts: schistosomiasis. N Engl J Med 297: 329‑1331, 1977.
Mahmoud AAF, Stone MK and Kellermeyer RW. Eosinophilopoietin: a low molecular weight peptide stimulating eosinophil production in mice. Trans Assoc Am Physicians 90:127‑134, 1977.
Stevens DP, Frank D and Mahmoud AAF. Thymus dependency of host resistance to Giardia muris infection: Studies in nude mice. J Immunol 120:680‑682, 1978.
Mahmoud AAF and Woodruff AW. Causation of splenomegaly in schistosomiasis. Clin Sci Mol Med 54: 97‑401, 1978.
Civil RH and Mahmoud AAF. Genetic differences in BCG‑induced resistance to Schistosoma mansoni are not controlled by genes within the major histocompatibility complex of the mouse. J Immunol 120:1070‑1072, 1978.
Mandel AF and Mahmoud AAF. Impairment of cell‑mediated immunity in mutation diabetic mice (db/db). J Immunol 120:1375‑1377, 1978.
Civil RH, Warren KS and Mahmoud AAF. Conditions for Bacille Calmette‑Guerin induced resistance to injection with Schistosoma mansoni in mice. J Infect Dis 137:550‑555, 1978.
Kassis AI, Warren KS and Mahmoud AAF. The Schistosoma haematobium egg granuloma. Cell Immunol 38:310‑318, 1978.
Densen P, Mahmoud AAF, Sullivan J, Warren KS and Mandell GL. Demonstration of eosinophil degranulation on the surface of opsonized schistosomules by phase contrast cinemicrography. Infec. Immun 22:282‑285, 1978.
Smith DH, Warren KS and Mahmoud AAF. Morbidity in schistosomiasis mansoni in relation to intensity of infection: study of a community in Kisumu , Kenya . Am J Trop Med Hyg 28:220‑230, 1979.
Kassis AI, Aikawa M and Mahmoud AAF. Mouse antibody‑dependent eosinophil and macrophage adherence and damage to schistosomula of Schistosoma mansoni. J Immunol 122:398‑405, 1979.
Mahmoud AAF. Host‑parasite relationship in schistosomiasis mansoni in the mutation diabetic mouse (db/db). Am J Trop Med Hyg 28:286‑290, 1979.
Mahmoud AAF, Peters PAS, Civil RH and Remington JS. In vitro killing of schistosomula of Schistosoma mansoni by BCG and C. parvum activated macrophages. J Immunol 122: 655‑1657, 1979.
Warren KS, Mahmoud AAF, Muruka JF, Whittaker LR, Ouma JH and Siongok TK Arap. Schistosomiasis hameatobium in Coast Province Kenya . Am J Trop Med Hyg 28: 864‑870, 1979.
Dunn MA, Kamel R, Kamel IA, Biempica L, El Kholy A, Hait PK, Rojkind M, Warren KS and Mahmoud AAF. Liver collagen synthesis in schistosomiasis mansoni. Gastroenterology 76: 978‑982, 1979.
Reiner NE, Kamel R, Higashi GI, El Naggar A, Aguib M, Ellner JJ and Mahmoud AAF. Concurrent peripheral blood and spleen mononuclear cell responses to antigenic and mitogenic stimulation in human hepatosplenic schistosomiasis mansoni: effect of adherent cell depletion. J Infect Dis 140:162‑168, 1979.
Ellner JJ and Mahmoud AAF. Killing of schistosomula of Schistosoma mansoni by normal human monocytes. J Immunol 123:949‑951, 1979.
Abdel Salam E, Ishaac S and Mahmoud AAF. Histocompatibility‑linked susceptibility for hepatosplenomegaly in human schistosomiasis mansoni. J Immunol 123: 829‑1831, 1979.
Kazura JW, Gandola C, Rodman HR and Mahmoud AAF. Deficient production of the lymphokine eosinophil stimulation promoter in chemically‑induced and mutation diabetes mellitus in mice. J. Immunol. 123:2114‑2117, 1979.
Kassis AI, Warren KS and Mahmoud AAF. Antibody‑dependent complement‑mediated killing of schistosomula in intraperitoneal diffusion chambers in mice. J Immunol 123:1659‑1661, 1979.
Mahmoud AAF, Stone MK and Tracy JW. Eosinophilopoietin production: Relationship to eosinophilia of infection and thymus function. Trans Assoc Am Physicians 92:355‑359, 1979.
Peters PA, El Alamy M, Warren KS and Mahmoud AAF. Quick Kato smear for field quantification of Schistosoma mansoni eggs. Am J Trop Med Hyg 29:217‑219, 1980.
Olanoff LS, Mahmoud AAF and Anderson JM. Controlled release of niridazole from silicone rubber implants for the treatment of Schistosoma mansoni infections. Am J Trop Med Hyg 29:71‑73, 1980.
Tebbi CK, Mahmoud AAF, Polmar S and Gross S. The role of eosinophils in granulopoiesis: I. Eosinophilia in neutropenic patients. Pediatrics 96:575‑582, 1980.
Olds GR, Chedid L, Lederer E and Mahmoud AAF. Induction of resistance to Schistosoma mansoni by natural cord factor and synthetic lower homologues. J Infect Dis 141: 473‑478,1980.
Ellner JJ, Olds GR, Kamel R, Osman G, El Kholy A and Mahmoud AAF. Suppressor splenic T lymphocytes in human hepatosplenic schistosomiasis mansoni. J Immunol 125:308‑312, 1980.
Olds GR, Ellner JJ, Kearse LA Jr, Kazura JW and Mahmoud AAF. Role of arginase in killing of schistosomula of Schistosoma mansoni. J Exp Med 151:1557‑1562, 1980.
Bartelmez SH, Dodge WH, Mahmoud AAF and Bass DA. Stimulation of eosinophil production in vitro by eosinophilopoietin and spleen cell‑derived eosinophil growth stimulating factor. Blood 56:706‑711, 1980.
Domingo EO, Tiu E, Peters PA, Warren KS, Mahmoud AAF and Houser HB. Morbidity in schistosomiasis japonica in relation to intensity of infection: study of a community in Leyte , Philippines . Am J Trop Med Hyg 29: 858‑867, 1980.
Olds GR and Mahmoud AAF. he role of host granulomatous response in murine schistosomiasis mansoni: eosinophil‑mediated destruction of eggs. J Clin Invest 66:1191‑1199, 1980.
Ellner JJ, Olds GR, Osman GS, El Kholy A and Mahmoud AAF. Dichotomies in the reactivity to worm antigen in human schistosomiasis mansoni. J Immunol 126:309‑312, 1981.
Kazura JW, Fanning M, Blumer JT and Mahmoud AAF. Role of cell‑generated H2O2 in granulocyte‑mediated killing of schistosomula of Schistosoma mansoni in vitro. J Clin Invest 67:93‑102, 1981.
Kazura JW, Fanning M and Mahmoud AAF. Granulocyte cytotoxicity to multicellular organisms is mediated by peroxidative mechanisms. Trans Assoc Am Phys 93:336‑340, 1981.
Jong EC, Mahmoud AAF and Klebanoff SJ. Peroxidase‑mediated toxicity to schistosomula of Schistosoma mansoni. J Immunol 126:468‑471, 1981.
Menitove JE, Rassiga AL, McLaren GD, Daniel TM and Mahmoud AAF. Antigranulocyte antibodies and deranged immune function with phenytoin‑induced serum sickness. Am J Hematol 10:277‑284, 1981.
Olds GR and Mahmoud AAF. Kinetics and mechanisms of pulmonary granuloma formation around Schistosoma japonicum eggs injected into mice. Cell Immunol 60:251‑260, 1981.
Garb KS , Stavitsky AB and Mahmoud AAF. Dynamics of antigen and mitogen induced responses in murine schistosomiasis japonica: In vitro comparison between hepatic granulomas and splenic cells. J Immunol 127:115‑120, 1981.
Fanning MM, Peters PA, Davis RS, Kazura JW and Mahmoud AAF. Immunopathology of murine schistosomiasis mansoni: relationship of genetic background to heptosplenic disease and modulation. J Infect Dis 144:148‑153, 1981.
Hewlett EL, Hamid OYA, Ruffier J and Mahmoud AAF. In vivo suppression of delayed hypersensitivity by thiabendazole and diethylcarbamazine. Immunopharmacology 3:325‑332, 1981.
Olveda RM, Olds GR and Mahmoud AAF. Quantification, dynamics, and mechanisms of the pulmonary inflammatory response around schistosomula of Schistosoma mansoni. Am J Pathol 104:150‑159, 1981.
Olds GR, Ellner JJ, El Kholy A and Mahmoud AAF. Monocyte killing of schistosomula of Schistosoma mansoni: Alterations in human schistosomiasis mansoni and tuberculosis. J Immunol 127: 538‑1542, 1981.
Orrego H, Israel Y, Crossley IR, Mahmoud AAF, Peters PA, Garghese G and Wanless IR. Effect of chronic alcohol intake on hepatic fibrosis and granulomas in murine schistosomiasis mansoni. Hepatology 1:416‑418, 1981.
Mahmoud AAF. The ecology of eosinophils in schistosomiasis. J Infect Dis 145:613‑622, 1981.
Olds G.R, Olveda R, Tracy JW and Mahmoud AAF. Adoptive transfer of modulation of granuloma formation and hepatosplenic disease in murine schistosomiasis japonica by serum from chronically infected animals. J Immunol 128:1391‑1393, 1982.
Hamburger J, Lustigman L, Siongok TKA, Ouma JH and Mahmoud AAF. Characterization of a purified glycoprotein from Schistosoma mansoni egg: Specificity, stability and the involvement of carbohydrate and peptide moities in its serologic activity. J Immunol 128:1864‑1875, 1982.
Hamburger J, Lustigman S, Siongok TKA, Ouma JH and Mahmoud AAF. Analysis and preliminary purification of glycoproteins isolated from eggs in the urine of patients with Schistosoma haematobium infection. J. Immunol 129:1711‑1714, 1982.
Garb KS , Stavitsky AB , Olds GR, Tracy JW and Mahmoud AAF. Immune regulation in murine schistosomiasis japonica. Inhibition of an in vitro antigen‑ and mitogen‑induced cellular responses by splenocyte culture supernatants and by purified fractions from serum of chronically infected mice. J Immunol 129:2752‑2758, 1982.
Tracy .W and Mahmoud AAF. Isolation of Schistosoma japonicum egg glycoprotein antigens which sensitize mice to lung granuloma formation and elicit an immediate hypersensitivity response. Am J Trop Med Hyg 31:1201‑1212, 1982.
Peck CA, Carpenter MD and Mahmoud AAF. Species‑related innate resistance to schistosomiasis mansoni: Role of mononuclear phagocytes in schistosomula killing in vitro. J Clin Inves. 71:66‑72, 1983.
Mahmoud AAF, Siongok TK Arap Ouma J, Houser HB and Warren KS. Effect of targeted mass treatment on intensity of infection and morbidity in schistosomiasis mansoni: 3‑year follow‑up of a community in Machakos , Kenya . Lancet, April 16: 849‑851, 1983.
El Kholy A, Boutros S, Tamara F, Warren KS and Mahmoud AAF. The effect of a single dose of metrifonate on Schistosoma haematobium infection in Egyptian school children. Am J Trop Med Hyg 33:1170‑1172, 1984.
Brito P, Kazura JW and Mahmoud AAF. Host granulomatous response in schistosomiasis mansoni: Antibody and cell mediated damage of parasite eggs in vitro. J Clin Inves. 74:1715‑1723, 1984.
Tracy JW, Domingo EO and Mahmoud AAF. Evaluation of a purified Schistosoma japonicum glycoprotein egg antigen for the immunodiagnosis of infection in man. Am J Trop Med Hyg 34:92‑95, 1985.
Kaplan BS, Uni S, Aikawa M and Mahmoud AAF. Effector mechanisms of host resistance in murine giardiasis: Specific IgG and IgA cell‑mediated toxicity. J Immunol 134:1975‑1981, 1985.
Lustigman S, Mahmoud AAF and Hamburger J. Glycopeptides in soluble egg antigen of Schistosoma mansoni: Isolation, characterization and elucidation of their immunochemical and immunopathological relation to the major egg glycoprotein (MEG). J Immunol 134:1961‑1967, 1985.
Sturrock RF, Cottrell BJ, Mahmoud AAF, Chedid L and Kimani R. Attempts to induce resistance to schistosomiasis in Kenyan baboons (Papio anubis). 2. Use of non‑specific stimulants. Parasitology 90:101‑110, 1985.
Blanton RE, Davis AH, Rottman F, Maurer R and Mahmoud AAF. Three developmentally regulated genes identified by clones from an adult Schistosoma mansoni cDNA expression library. Trans. Assoc. Am. Phys. 98:101‑106, 1985.
King CH, Peck CA, Haimes CS, Kazura JW, Spagnuolo P, Sawyer JA, Olds GR and Mahmoud AAF. Modulation of human neutrophil effector functions by monoclonal antibodies against surface membrane molecules of 94,000 and 180,000 molecular weight. Blood 67:188‑194, 1986.
Abdel Salam E, Abdel Khalik A, Abdel Meguid A, Barakat W and Mahmoud AAF. Association of HLA class I antigens (A1, B5, B8 and CW2) with disease manifestations and infection in human schistosomiasis mansoni in Egypt . Tissue Antigens 23:142‑146, 1986.
Abdel‑Salam E, Peters PAS, Abdel Meguid AE, Abdel Meguid AAE and Mahmoud AAF. Discrepancies in outcome of a control program for schistosomiasis haematobia in Fayoum governorate, Egypt . Am J Trop Med Hyg 35:786‑790, 1986.
Davis AH, Blanton R, Rottman F, Maurer R and Mahmoud AAF. Isolation of cDNA clones for differentially expressed genes of the human parasite Schistosoma mansoni. Proc Natl Acad Sci 83:5534‑5538, 1986.
Blanton R, Horowitz S, Dos Reis MG, Rottman F and Mahmoud AAF. Stage and species specificity of antigens encoded by two geographic strains of Schistosoma mansoni mRNA. J Parasitol 72:445‑453, 1986.
King CH, Goralnik CSH, Kleinhenz PJ, Marino JA, Sedor JR and Mahmoud AAF. Monoclonal antibody characterization of a chymotrypsin‑like molecule on neutrophil membrane which is required for cellular activation. J Clin Invest 79:1091‑1098, 1987.
King CJ, Lett RR, Nanduri J, El Ibiary S, Peters PAS, Olds GR and Mahmoud AAF. Isolation and characterization of a protective antigen for adjuvant‑free immunization against Schistosoma mansoni. J Immunol 139:4218‑4224, 1987.
Wiest PM, Tartakoff AM, Aikawa M and Mahmoud AAF. Inhibition of heptalminate surface membrane maturation in schistosomula of Schistosoma mansoni. Proc Natl Acad Sci 85:3825‑3830, 1988.
King CH, Keating CE, Muruka JF, Ouma JH, Houser H, Siongok TK Arap and Mahmoud AAF. Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province , Kenya . Am J Trop Med Hyg 39:363‑370, 1988.
King CH, Lombardi G, Lombardi C, Greenblatt R, Hodder S, Kinyanjui H, Ouma J, Odiambo O, Bryan PJ, Muruka J, Magak P, Weinert D, Mackay W, Ransohoff D, Houser H, Koech D, Siongok TK Arap and Mahmoud AAF. Chemotherapy‑based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg 39:295‑305, 1988.
Matsumoto Y, Perry G, Levine RJC, Blanton R, Mahmoud AAF and Aikawa M. Paramyosin and actin in schistosomal teguments. Nature 333 (6168):76‑78, 1988.
Wiest PW, Tisdale R, Rosenberry T, Mahmoud AAF and Tartakoff AM. Characterization of 3H palmitate 3H ethanolamine labelled protein in Schistosoma mansoni. Biochem. J 254:419‑426, 1988.
Schiltz JR, Olds GR, Kresina TF and Mahmoud AAF. Effect of chemotherapy on hepatic collagen and glycosaminoglycan metabolism in Schistosoma mansoni infected mice. Trans Roy Soc Trop Med Hyg 82:868‑873, 1988.
El Meneza S, Olds GR, Kresina TF and Mahmoud AAF. Dynamics of hepatic connective tissue matrix constituents during murine Schistosoma mansoni infection. Hepatology 9:50‑56, 1989.
King CH, Mahmoud AAF. Drugs five years later: praziquantel. Ann. Int. Med. 110:290‑296, 1989.
Olds GR, El Meneza S, Mahmoud AAF and Kresina TF. Differential immunoregulation of granulomatous inflammation, portal hypertension and hepatic fibrosis in murine schistosomiasis mansoni. J Immunol 142:3605‑3611, 1989.
Flanigan TP, King CH, Lett RR, Nanduri J and Mahmoud AAF. Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin. J Clin Inves. 83:1010‑1014, 1989.
Mahmoud AAF. Parasitic protozoa and helminths: Biological and immunological challenges. Science 246:1015‑1022, 1989.
El Kholy H, Siongok T K Arap, Koech D, Sturrock RF, Houser H, King CH and Mahmoud AAF. Effects of borehole wells on water utilization in S. haematobium‑endemic communities in Coast Province , Kenya . Am J Trop Med Hyg 41:212‑219, 1989.
King CH, El Ibiary S, El Nawawi M, Sawyer J, Griffin A, El Hawey A and Mahmoud AAF. Intensity of Schistosoma mansoni infection in a human population is inversely correlated with antibody response to SMW68, a protective parasite antigen. J Infect Dis 160:686‑691, 1989.
DeStigter KV, King CH, Keating CE, Ouma JH, Siongok TKA and Mahmoud AAF. Effect of targeted mass treatment on intensity of infection and morbidity in schistosomiasis mansoni: 7‑year follow‑up of a community in Machakos , Kenya . Trans Am Assoc Phys 102:209-212, 1989.
Mahmoud AAF. Strategies for Vaccine Development: Schistosomiasis. Ann NY Acad Science 569:136-144, 1989.
Sturrock RF, Kinyanjui H, Thiongo FW, Tosha S, Ouma JH, King CH, Koech D, Siongok TK Arap and Mahmoud AAF. Chemotherapy‑based control of schistosomiasis haematobia. III. Snail studies monitoring the effect of chemotherapy on transmission in the Msambweni area, Kenya . Trans Roy Soc Trop Med Hyg 84:257-261, 1990.
King CH, Lombardi G, Lombardi C, Greenblatt R, Hodder S, Kinyanjui H, Ouma J, Odiambo O, Bryan PJ, Muruka J, Magak P, Weinert D, Ransohoff D, Houser H, Koech D, Arap Siongok TK and Mahmoud AAF. Chemotherapy-based control of schistosomiasis haematobia. II. Metrifonate vs. praziquantel in control of infection-associated morbidity. Am J Trop Med Hyg 42:587-595, 1990.
Nanduri J, Dennis JE, Rosenberry TH, Mahmoud AAF, Tartakoff AM. Glycocalyx of bodies vs. tails of Schistosoma mansoni cercariae: lectin binding, size, charge, and electronmicroscopic characterization. J Biol Chem 266:1341-1347, 1991.
Blanton RE, Matsumoto Y, Peters PA, El Biary S, King CH, Mahmoud AAF, Aikawa M. Ultrastructural localization of a protective 68,000 molecular weight antigen in Schistosoma mansoni. Am J Trop Med, 45:112-120, 1991.
Mahmoud AAF. The Challenge of Intracellular Pathogens. New Eng J Med 326:761-762, 1992.
Mahmoud AAF. Schistosomiasis: An Overview. Immunological Investigations 21(5):383-390, 1992.
Mahmoud AAF. Young Investigators: The Future of Medicine. J Lab Clin Med 119:205, 1992.
Mahmoud AAF. Academic Medicine: The Social Consciousness of the Profession. J Lab Clin Med 121:635-637, 1993.
Abdel-Salam E, Fawzy M, Abdel-Meguid IE, Kamel S, Hawrey EI and Mahmoud AAF. Impact of Targeted Long-Term Chemotherapy-Based Program on Prevalence, Intensity, and Morbidity of Schistosomiasis Haematobia in Egyptian Children. Intl Child Health, Volume V, No. 3:91-102, 1994.
King C, Jia X, Malhotra I, Mahmoud AAF, Oettgen H Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni. J Immunol 158:294-300, 1997.
Mahmoud AAF. Epidemiology of parasitic protozoan and helminthic infections in the United States of America . Clinical Infections & Chemotherapy 3:43-45, 1997.
Takeda Y and Mahmoud AAF. Collaborative research and training programs in infectious diseases: summary of roundtable discussion. FEMS Immmunology and Medical Microbiology, 18:333-336, 1997.
Mahmoud AAF. Global Dynamics of Parasitic Diseases. Clinical Parasitology 8:16-18, 1997.
Mahmoud AAF, La Montagne JL, Takeda Y. Summary of the International Conference on Emerging Infectious Diseases US-Japan Cooperataive Medical Science Program, Bangkok , 1997. J Infect Dis 177:3-4, 1998.
Sang DK, Ouma JH, John CC, Whalen CC, King CL, Mahmoud AAF, Heinzel FP. Increased levels of soluble Interleukin-4 receptor in the sera of patients with visceral Leishmaniasis. J Infect Dis 179:743-746; 1999.
Subramanian AK, Mungai P, Ouma JH, Magak P, King CH, Mahmoud AAF, King CL. Long-term suppression of adult bladder morbidity and severe hydronephrosis following selective population chemotherapy for schistosoma haematobium. Am J Trop Med Hyg 61:476-481, 1999.
Murray HW, Pepin J, Nutman TB, Hoffman SL, Mahmoud AAF. Clinical Review. Recent Advances in Tropical Medicine. BMJ. 320:490-494, 2000.
Hodder SL, Mahmoud AAF, Sorenson K, Weinert DM, Stein RL, Ouma JH, Koech D, King CH. Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection. Am J Trop Med Hyg 63:133-138, 2000.
Mahmoud AAF, Lemon S. Summary and assessment. In biological threats and terrorism: Assessing the science and response capabilities, Knobler SL, Mahmoud AAF, Pray LA (eds). The National Academies Press, Washington DC , pp. 1-19, 2002.
Mahmoud AAF, Lemon SM. Summary and assessment. In learning from SARS. Preparing for the next disease outbreak. Knobler S, Mahmoud A, Lemon S, Mack A, Sivitz L, Oberholtzer K (eds). The National Academies Press, Washington DC , pp. 1-39, 2004.
Mahmoud AAF. Schistosomiasis (bilharziasis): from antiquity to the present. Infect Dis Clin N Am 18:207-218, 2004.
Mahmoud A. Editorial: The Global Vaccination Gap. Science 305:147, 2004.
Mahmoud A. The Vaccine Enterprise : time to act. Health Affairs 24:596-597, 2005.
Mahmoud A., Frederick C. Robbins, 1916-2003, A Biographical Memoir. Biographical Memoirs 88 National Academy of Sciences, 2006
Mahmoud A., Modeling Community Containment for Pandemic Influenza: A Letter report. Institute of Medicine . The National Academies Press, Washington DC , 2006, 36pp.
Mahmoud A, The March of HIV Vaccines. Science 316: 1123 – 1124, 2007
Mahmoud A, Levin M. Vaccines at the turn of 21st Century: A new era for immunization in Public Health. Int J Infect Dis., in press, 2007